Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
Authors
Keywords
-
Journal
Oncogenesis
Volume 4, Issue 11, Pages e177-e177
Publisher
Springer Nature
Online
2015-11-30
DOI
10.1038/oncsis.2015.35
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extremophilic polysaccharide nanoparticles for cancer nanotherapy and evaluation of antioxidant properties
- (2015) Sreejith Raveendran et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells
- (2015) Zuochong Yu et al. International Journal of Nanomedicine
- Chemoradiation therapy using cyclopamine-loaded liquid–lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles
- (2015) Jian You et al. JOURNAL OF CONTROLLED RELEASE
- Codelivery of Small Molecule Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer
- (2015) Virender Kumar et al. MOLECULAR PHARMACEUTICS
- Extremophilic Polysaccharide for Biosynthesis and Passivation of Gold Nanoparticles and Photothermal Ablation of Cancer Cells
- (2014) Sreejith Raveendran et al. PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION
- Hyaluronic Acid-Based Nanogel–Drug Conjugates with Enhanced Anticancer Activity Designed for the Targeting of CD44-Positive and Drug-Resistant Tumors
- (2013) Xin Wei et al. BIOCONJUGATE CHEMISTRY
- Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell properties
- (2013) Monica Bostad et al. JOURNAL OF CONTROLLED RELEASE
- CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer
- (2013) Suresh Kumar Swaminathan et al. JOURNAL OF CONTROLLED RELEASE
- Anti-ABCG2 monoclonal antibody in combination with paclitaxel nanoparticles against cancer stem-like cell activity in multiple myeloma
- (2013) Cuiping Yang et al. Nanomedicine
- Aptamer conjugated theragnostic multifunctional magnetic nanoparticles as a nanoplatform for pancreatic cancer therapy
- (2013) Balasubramanian Sivakumar et al. RSC Advances
- Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous Cell carcinoma-derived cancer stem cells
- (2012) Wen-Liang Lo et al. BIOMATERIALS
- Bacterial exopolysaccharide based nanoparticles for sustained drug delivery, cancer chemotherapy and bioimaging
- (2012) Sreejith Raveendran et al. CARBOHYDRATE POLYMERS
- Current Status of Therapeutic Targeting of Developmental Signalling Pathways in Oncology
- (2012) Tobias Kiesslich et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Synergistic Targeting of Cancer and Associated Angiogenesis Using Triple-Targeted Dual-Drug Silica Nanoformulations for Theragnostics
- (2012) Srivani Veeranarayanan et al. Small
- DNA−Gold Nanoparticle Reversible Networks Grown on Cell Surface Marker Sites: Application in Diagnostics
- (2011) Kyuwan Lee et al. ACS Nano
- Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
- (2011) K Pandya et al. BRITISH JOURNAL OF CANCER
- A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors
- (2011) Kah Jing Lim et al. CANCER BIOLOGY & THERAPY
- Polymeric Nanoparticle-Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma
- (2011) Yang Xu et al. CLINICAL CANCER RESEARCH
- Overcoming drug resistance in pancreatic cancer
- (2011) Jiang Long et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cancer Stem-Like Cells Enriched in Panc-1 Spheres Possess Increased Migration Ability and Resistance to Gemcitabine
- (2011) Tao Yin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Down-regulation of BMI-1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells
- (2011) Jing Wu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2011) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Topical Treatment of Basal Cell Carcinomas in Nevoid Basal Cell Carcinoma Syndrome with a Smoothened Inhibitor
- (2011) Hans Skvara et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Polymeric Nanoparticle Encapsulated Small-Molecule Inhibitor of Hedgehog Signaling (NanoHHI) Bypasses Secondary Mutational Resistance to Smoothened Antagonists
- (2011) V. Chenna et al. MOLECULAR CANCER THERAPEUTICS
- Mesoporous Silica Nanoparticles as Drug Delivery Systems for Targeted Inhibition of Notch Signaling in Cancer
- (2011) Veronika Mamaeva et al. MOLECULAR THERAPY
- Common Botanical Compounds Inhibit the Hedgehog Signaling Pathway in Prostate Cancer
- (2010) A. Slusarz et al. CANCER RESEARCH
- The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors
- (2010) Prashant V. Bommi et al. CELL CYCLE
- (−)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells
- (2010) Guo-Qing Tang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- FC24 LDE225, a specific smoothened inhibitor, for the topical treatment of nevoid basal cell carcinoma syndrome (Gorlinʼs syndrome)
- (2010) A. Stuetz et al. MELANOMA RESEARCH
- Evaluation of Selective -Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
- (2010) P. Wei et al. MOLECULAR CANCER THERAPEUTICS
- Targeting breast cancer stem cells
- (2010) Sean P. McDermott et al. Molecular Oncology
- Sulforaphane Increases Drug-mediated Cytotoxicity Toward Cancer Stem-like Cells of Pancreas and Prostate
- (2010) Georgios Kallifatidis et al. MOLECULAR THERAPY
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Acute Myeloid Leukemia and the Wnt Pathway
- (2010) Connie J. Eaves et al. NEW ENGLAND JOURNAL OF MEDICINE
- Wnt signal transduction pathways
- (2010) Yuko Komiya et al. Organogenesis
- Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
- (2009) Z. Wang et al. CANCER RESEARCH
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Direct inhibition of the NOTCH transcription factor complex
- (2009) Raymond E. Moellering et al. NATURE
- Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
- (2009) Chen Zhao et al. NATURE
- A small molecule that binds Hedgehog and blocks its signaling in human cells
- (2009) Benjamin Z Stanton et al. Nature Chemical Biology
- β-Catenin hits chromatin: regulation of Wnt target gene activation
- (2009) Christian Mosimann et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics
- (2009) Y. WANG et al. NEOPLASMA
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
- (2009) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade
- (2009) J. M. Hyman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
- (2009) G. Bertolini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
- (2009) Hasan Korkaya et al. PLOS BIOLOGY
- Pygopus and the Wnt signaling pathway: A diverse set of connections
- (2008) Shannon Jessen et al. BIOESSAYS
- Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation
- (2008) Christine Dierks et al. CANCER CELL
- A Notch1 Ectodomain Construct Inhibits Endothelial Notch Signaling, Tumor Growth, and Angiogenesis
- (2008) Y. Funahashi et al. CANCER RESEARCH
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation
- (2008) Xiaoyun Liao et al. CARCINOGENESIS
- Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells
- (2008) Elisabetta Ferretti et al. EMBO JOURNAL
- Prostate Cancer Stem Cells: A New Target for Therapy
- (2008) Norman J. Maitland et al. JOURNAL OF CLINICAL ONCOLOGY
- A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes
- (2008) Yang Liu et al. JOURNAL OF CONTROLLED RELEASE
- Prostate cancer stem cells
- (2008) SH Lang et al. JOURNAL OF PATHOLOGY
- Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling
- (2008) Ilaria Malanchi et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More